Front Row Advisors LLC - CARDIFF ONCOLOGY INC ownership

Quarter-by-quarter ownership
Front Row Advisors LLC ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q3 2023$320.0%0.00%
Q2 2023$020.0%0.00%
Q1 2023$020.00%
Q4 2022$00
-100.0%
0.00%
Q1 2022$020.0%0.00%
Q4 2021$020.0%0.00%
Q3 2021$020.0%0.00%
Q2 2021$020.0%0.00%
Q4 2020$020.0%0.00%
Q3 2020$020.0%0.00%
Q2 2020$020.00%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q4 2023
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 120,600$265,0000.37%
Artal Group S.A. 750,000$1,650,0000.09%
XTX Topco Ltd 55,081$121,0000.05%
GSA CAPITAL PARTNERS LLP 117,295$258,0000.04%
ELKHORN PARTNERS LIMITED PARTNERSHIP 23,800$52,0000.03%
Atom Investors LP 33,798$74,0000.03%
CHARTWELL INVESTMENT PARTNERS, LLC 296,507$652,0000.03%
Laurion Capital Management LP 722,100$1,589,0000.02%
MYDA Advisors LLC 30,000$66,0000.02%
Ergoteles LLC 184,000$405,0000.01%
View complete list of CARDIFF ONCOLOGY INC shareholders